Blood test may predict lung nodule danger
NCT ID NCT07647484
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 200 adults who have had one lung nodule removed but still have other nodules in their lungs. Researchers will collect small blood samples during routine check-ups to study immune cells and virus-related markers. The goal is to see if certain immune patterns are linked to whether the remaining nodules stay stable or grow over time. No treatments or changes to standard care are involved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict which lung nodules may grow or become dangerous, improving follow-up care.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly help participants and may not lead to any new tests or therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE PULMONARY NODULES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood immune signatures may reveal clues about lung nodule behavior
- Robot-Assisted combo treatment aims to ease lung nodule recovery
- Robot-Assisted lung biopsy under the microscope: will it deliver?
- Lung nodule diagnosis sparks new push to help veterans quit smoking
- Could a Pre-Surgery immune drug shrink early lung cancer nodules?